Cargando…

A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice

BACKGROUND: Immune responses are important in the progression of non-alcoholic fatty liver disease (NAFLD). Natural killer T (NKT) cells are main components of the innate immune system that modulate immunity. However, the role of NKT cells in NAFLD remains controversial. OBJECTIVE: We aimed to inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Shumei, Yang, Wenzhuo, Yao, Dongmei, Tang, Shanhong, Hou, Juanni, Chang, Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Gastroenterology – Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377241/ https://www.ncbi.nlm.nih.gov/pubmed/35950602 http://dx.doi.org/10.1080/07853890.2022.2108894

Ejemplares similares

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
por: Armstrong, Matthew J, et al.
Publicado: (2013)

Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
por: Angelini, Giulia, et al.
Publicado: (2023)

Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
por: Amin, Neeta B, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey
por: Nadolsky, Karl, et al.
Publicado: (2023)

Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study
por: Coelho, Juliana Moraes, et al.
Publicado: (2020)

The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018
por: Liu, Jie, et al.
Publicado: (2022)

Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study
por: Mettananda, Chamila, et al.
Publicado: (2023)

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol
por: Dhanda, Ashwin D, et al.
Publicado: (2022)

The role of hepatic microenvironment in hepatic fibrosis development
por: Meng, Ying, et al.
Publicado: (2022)

Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway
por: Wu, Shan, et al.
Publicado: (2023)

Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017–2018
por: Ji, Yuan, et al.
Publicado: (2023)

Hepatic fibrosis and factors associated with liver stiffness in HIV mono-infected individuals
por: Sulyok, Mihály, et al.
Publicado: (2017)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Close association of PFASs exposure with hepatic fibrosis than steatosis: evidences from NHANES 2017–2018
por: Cheng, Wenli, et al.
Publicado: (2023)

Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction
por: Choi, Jong Wook, et al.
Publicado: (2019)

Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study
por: Tang, Xiaoping, et al.
Publicado: (2022)

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
por: Poynard, Thierry, et al.
Publicado: (2015)

Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study
por: Nah, Eun-Hee, et al.
Publicado: (2021)

Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study
por: Park, Jung Gil, et al.
Publicado: (2020)

Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
por: Jarvis, Helen, et al.
Publicado: (2022)

Adiponectin–leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance
por: Lu, Chia-Wen, et al.
Publicado: (2023)

Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
por: Koh, Eun Hee, et al.
Publicado: (2021)

KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study
por: Oudmaijer, Christiaan Albert Johan, et al.
Publicado: (2022)

Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD)? protocol for a feasibility randomised controlled trial
por: Subhani, Mohsan, et al.
Publicado: (2021)

Study protocol to investigate the efficacy of confocal laser endomicroscopy-based selective single-elimination diet over standard fivefold elimination diet in patients with endomicroscopically proven food intolerance: app-assisted, monocentric, double-blind, randomised and controlled trial in Germany
por: Heßler, Nicole, et al.
Publicado: (2023)

Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease
por: Weinstein, Ali A., et al.
Publicado: (2023)

Stages of psychological change among patients with non-alcoholic fatty liver disease in China: a national cross-sectional study
por: Huang, Rui, et al.
Publicado: (2023)

Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-β1/Smad pathway: implications for liver cancer
por: Peng, Xiongqun, et al.
Publicado: (2023)

Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China
por: Huanan, Chen, et al.
Publicado: (2020)

Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study
por: Ocskay, Klementina, et al.
Publicado: (2022)

Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors
por: O'Hara, Geraldine, et al.
Publicado: (2020)

Feasibility and acceptability of a primary care liver fibrosis testing pathway centred on the diabetes annual review: PRELUDE1 prospective cohort study protocol
por: Brindley, James Hallimond, et al.
Publicado: (2023)

Dose–response association between physical activity and non-alcoholic fatty liver disease: a case–control study in a Chinese population
por: Li, YangFan, et al.
Publicado: (2019)

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial
por: Haigh, Laura, et al.
Publicado: (2021)

Impact of gastrointestinal conditions, restrictive diets and mental health on health-related quality of life: cross-sectional population-based study in Australia
por: Stocks, Nigel P, et al.
Publicado: (2019)

Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors
por: Wieser, Verena, et al.
Publicado: (2017)

Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population
por: Hung, Wei-Chieh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_trjnksujtgcme0f4m9dqsslpgk